Genetically manipulated virus could prevent mosquitoes from transmitting malaria, study says

NewsGuard 100/100 Score

A genetically manipulated version of densovirus could prevent Anopheles gambiae mosquitoes from transmitting malaria, according to a study published last week in PLoS Pathogens, the New York Times reports.

Jason Rasgon, an entomology professor at Johns Hopkins Malaria Research Institute, and colleagues discovered the densovirus "in a complete accident" while conducting separate research that involved infecting mosquitoes with bacteria (McNeil, New York Times, 8/25). The researchers found that the virus repeatedly appeared in a gel used to detect the bacteria. Although it is not "uncommon" to find viruses during experiments, the researchers decided to "investigate" the densovirus because it continued to appear, Rasgon said.

The researchers found that although the virus does not seem to harm the mosquitoes, it can infect mosquito larvae (PTI/Times of India, 8/26). To determine whether the virus could be manipulated, the researchers produced a harmless green fluorescent protein in adult mosquitoes, which could be spotted easily under microscopes (Malaria Research Institute release, 8/22).

According to Rasgon, scientists could manipulate the virus to produce a "lethal toxin" in infected mosquitoes to cause them to die after 10 days, which is long enough to prevent resistance to the virus from developing but too short for the mosquitoes to transmit malaria to humans (PTI/Times of India, 8/26). However, the research likely will take between five and 15 years because of regulatory and ethical issues associated with releasing the virus into wild mosquitoes, Rasgon said.

Densoviruses have been found in other insects but do not infect humans or other mammals, the Times reports (New York Times, 8/25).

The study is available online.


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative approaches needed to overcome health system barriers in malaria vaccination